| scholarly article | Q13442814 |
| P2093 | author name string | Amato Giaccia | |
| Gail McIntyre | |||
| Michael Dodds | |||
| Aaron Moss | |||
| David Prohaska | |||
| Laura Bonifacio | |||
| Ray Tabibiazar | |||
| P2860 | cites work | Antibody therapy of cancer | Q28262538 |
| A small molecule-kinase interaction map for clinical kinase inhibitors | Q29617451 | ||
| Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned? | Q33723852 | ||
| Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET. | Q34217927 | ||
| A model-based meta-analysis of monoclonal antibody pharmacokinetics to guide optimal first-in-human study design | Q34223916 | ||
| Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts | Q34380670 | ||
| An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis | Q34439798 | ||
| Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase | Q36556713 | ||
| Scaling pharmacodynamics from in vitro and preclinical animal studies to humans | Q37055123 | ||
| Reprogramming the immunological microenvironment through radiation and targeting Axl. | Q37541688 | ||
| Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies | Q37545045 | ||
| Molecular insights of Gas6/TAM in cancer development and therapy. | Q37745358 | ||
| Population Pharmacokinetics of Therapeutic Monoclonal Antibodies | Q37785528 | ||
| Molecular Pathways: Oncologic Pathways and Their Role in T-cell Exclusion and Immune Evasion-A New Role for the AXL Receptor Tyrosine Kinase | Q38746437 | ||
| Pharmacologic target-mediated drug disposition | Q40631377 | ||
| GAS6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl. | Q41091650 | ||
| General pharmacokinetic model for drugs exhibiting target-mediated drug disposition | Q43985366 | ||
| Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human prediction. | Q51612613 | ||
| P433 | issue | 1 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| pharmacodynamics | Q725307 | ||
| P304 | page(s) | 204-211 | |
| P577 | publication date | 2019-10-25 | |
| P1433 | published in | Clinical and Translational Science | Q5133809 |
| P1476 | title | Target-Mediated Drug Disposition Pharmacokinetic/Pharmacodynamic Model-Informed Dose Selection for the First-in-Human Study of AVB-S6-500 | |
| P478 | volume | 13 |
Search more.